%0
Generic
%T
Analysis of Outcomes in Diabetic Patients in a Phase 3 Trial of Nab-Paclitaxel (nab-P) Plus Carboplatin (C) in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
%A Hirsh, V.
%A Owen, S.P.
%A Ko, A.
%A Renschler, M.
%A Socinski, M.A.
%I Elsevier BV
%@ 0360-3016
%K Cancer Research
%K Radiology, Nuclear Medicine and imaging
%K Oncology
%K Radiation
%D 2014
%C Elsevier BV
%U http://slubdd.de/katalog?TN_libero_mab2